- Home
- PALI vs ACRE Comparison
PALI vs ACRE Comparison
Compare PALI & ACRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PALI
- ACRE
- Stock Information
- Founded
- PALI 1996
- ACRE 2011
- Country
- PALI United States
- ACRE United States
- Employees
- PALI N/A
- ACRE N/A
- Industry
- PALI Biotechnology: Biological Products (No Diagnostic Substances)
- ACRE Real Estate Investment Trusts
- Sector
- PALI Health Care
- ACRE Real Estate
- Exchange
- PALI Nasdaq
- ACRE Nasdaq
- Market Cap
- PALI 212.0M
- ACRE 242.6M
- IPO Year
- PALI N/A
- ACRE 2012
- Fundamental
- Price
- PALI $2.00
- ACRE $4.39
- Analyst Decision
- PALI Strong Buy
- ACRE Hold
- Analyst Count
- PALI 2
- ACRE 5
- Target Price
- PALI $12.00
- ACRE $4.83
- AVG Volume (30 Days)
- PALI 7.1M
- ACRE 323.8K
- Earning Date
- PALI 11-11-2025
- ACRE 11-07-2025
- Dividend Yield
- PALI N/A
- ACRE 13.64%
- EPS Growth
- PALI N/A
- ACRE N/A
- EPS
- PALI N/A
- ACRE N/A
- Revenue
- PALI N/A
- ACRE $80,674,000.00
- Revenue This Year
- PALI N/A
- ACRE N/A
- Revenue Next Year
- PALI N/A
- ACRE N/A
- P/E Ratio
- PALI N/A
- ACRE N/A
- Revenue Growth
- PALI N/A
- ACRE 58.54
- 52 Week Low
- PALI $0.53
- ACRE $3.35
- 52 Week High
- PALI $3.30
- ACRE $7.49
- Technical
- Relative Strength Index (RSI)
- PALI 60.77
- ACRE 39.55
- Support Level
- PALI $1.61
- ACRE $4.41
- Resistance Level
- PALI $2.14
- ACRE $4.50
- Average True Range (ATR)
- PALI 0.19
- ACRE 0.13
- MACD
- PALI -0.01
- ACRE -0.02
- Stochastic Oscillator
- PALI 75.86
- ACRE 13.64
About PALI Palisade Bio Inc.
Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and is researching PALI-1908.
About ACRE Ares Commercial Real Estate Corporation
Ares Commercial Real Estate Corp is a specialty finance company and a Real Estate Investment Trust providing commercial real estate loans and related investments. It operates in one segment namely originating and managing a diversified portfolio of CRE debt-related investments. The group recognizes its revenues through the interest income it receives from loans.